HIV coinfection with tuberculosis prevention

Jump to navigation Jump to search

HIV coinfection with tuberculosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating HIV coinfection with tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

HIV coinfection with tuberculosis prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV coinfection with tuberculosis prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV coinfection with tuberculosis prevention

CDC on HIV coinfection with tuberculosis prevention

HIV coinfection with tuberculosis prevention in the news

Blogs on HIV coinfection with tuberculosis prevention

Directions to Hospitals Treating HIV coinfection with tuberculosis

Risk calculators and risk factors for HIV coinfection with tuberculosis prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

A new epidemiological model, developed by WHO, UNAIDS and the Stop TB Partnership, shows it is possible to reduce HIV/AIDS deaths impressively through tuberculosis (TB) prevention and treatment. In 2009 almost one in four deaths among people living with HIV were due to TB, a disease that is both curable and preventable. The model estimates that through the scaled-up implementation of WHO-recommended collaborative TB/HIV activities, it is possible to save a million lives by the end of 2015.

Prevention

A publication 'Time to act: Save a million lives by 2015 – Prevent and treat tuberculosis among people living with HIV' was launched on June 6, 2011 at the UN headquarters in New York. It calls for the following actions:

  • Testing for HIV and TB should be provided every three years in places where both diseases are prevalent.
  • Prompt TB treatment needs to be provided to every person living with HIV with active TB - or else treatment to prevent TB.
  • HIV and TB treatment must be accessible and of good quality so that people living with HIV are cured of TB.
  • Antiretroviral therapy (ART) should be started early, which will help prevent TB, since people living with HIV are far less likely to become ill with and die of TB if they begin ART before their immune systems begin serious decline.
  • People who are HIV-positive and diagnosed with active TB should start ART regardless of the status of their immune systems.

References

Template:WH Template:WS